Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Namibia
Namibia: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 67.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Namibia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Namibia recorded 67.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025.
The figure is up 1.5% on the previous year and up 6.3% over five years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Namibia peaked at 79.0% in 2022 and was at its lowest, 0.0%, in 2000.
That places Namibia 144th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Namibia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 32.0% | — |
| 2018 | 50.0% | +56.2% |
| 2019 | 56.0% | +12.0% |
| 2020 | 63.0% | +12.5% |
| 2021 | 56.0% | -11.1% |
| 2022 | 79.0% | +41.1% |
| 2023 | 62.0% | -21.5% |
| 2024 | 66.0% | +6.5% |
| 2025 | 67.0% | +1.5% |
Namibia compared with similar countries
- Namibia's 67.0% is below the median for lower middle income countries, which is 70.0%, 96% of the median. (47 countries reporting)
- Namibia's 67.0% is above the median for Sub-Saharan Africa, which is 66.0%, 1.0× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 13.8% | 0.0% | 56.0% | 10 |
| 2020s | 65.5% | 56.0% | 79.0% | 6 |
Countries ranked near Namibia
More health data for Namibia
- Un projection of annual infant deaths, annual growth rate -1.75 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6445 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,046 deaths per 1,000 people (2090)
- Number of infants who die before age 1 561 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0644 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.56 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Namibia?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Namibia was 67.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Namibia?
- The highest recorded value was 79.0% in 2022.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Namibia?
- The lowest recorded value was 0.0% in 2000.
- How does Namibia rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Namibia ranks 144th out of 194 countries with data for 2025.
- Where does this Namibia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).